Accessibility Menu
Prenetics Global logo

Prenetics Global(NASDAQ) PRE

Market Cap$319.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-84%
5 Year-87%
1 Year+131%
1 Month+4%
$18.67
-2.96%
-0.57Today
After hours$18.57-$0.10 (-0.54%)
Prenetics Global last closing stock price
MetricPriceDate
Last closeUSD 18.642026-07-31
Prenetics Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.53%USD 18.742026-07-24
1 month+4.19%USD 17.892026-07-01
3 month+9.52%USD 17.022026-05-01
Year to date+18.35%USD 15.752025-12-31
1 year+130.98%USD 8.072025-07-31
3 year+80.1%USD 10.352023-08-01
5 year-87.12%USD 144.752021-07-30
Since inception-84.02%USD 116.632021-07-16

Prenetics Global Financials at a Glance

Market Cap

$319.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$113.75M

Net Income (TTM)

-$71.04M

EPS (TTM)

-$4.67

P/E Ratio

-3.99

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$18.67

Volume

42,540.64

Open

$19.06

Previous Close

$18.64

Daily Range

$18.41 - $19.57

52-Week Range

$7.18 - $23.63

Estimated Earnings Date

Aug 18, 2026

PRE News

DNA with icons and doctor

Why Prenetics Global Stock Is Skyrocketing Today

Keith SpeightsJan 10, 2023

PRE: Motley Fool Moneyball Superscore

66

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prenetics Global

Prenetics Global Limited is an investment holding company specializing in diagnostic and genetic testing services. The company offers a diverse range of products, including consumer-oriented genetic analysis and advanced health monitoring devices.

Products and Services
  • CircleDNA, a comprehensive genetic analysis solution
  • Circle HealthPod, for rapid COVID-19 detection
  • ColoClear, a non-invasive screening test for colorectal cancer
Growth Outlook
  • Revenue of $35.95 million reported in Q1 2026, showing potential for growth
  • Strong gross profit margin of 64.76% in the latest quarter
  • Significant cash reserves of $56.02 million as of March 2026
Financial Highlights
  • Net income of -$23.10 million in Q1 2026, indicating ongoing challenges
  • Current ratio of 5.15, reflecting strong liquidity position
  • Trailing twelve months (TTM) gross profit margin of 58.32%
Prenetics Global Limited operates in the healthcare sector, focusing on innovative diagnostic solutions. The company has developed a robust product line that caters to both consumer and professional markets, positioning itself well within the growing medical diagnostics industry. Despite facing challenges reflected in recent net income figures, the company maintains a strong liquidity position, as indicated by its current ratio. The significant gross profit margin suggests effective cost management and potential for profitability as the market expands. With a solid cash reserve, Prenetics is well-equipped to invest in future growth opportunities and navigate the evolving healthcare landscape.
AI Generated • Jul 29, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

98

CEO

Sheng Wu Yeung

Website

www.prenetics.com

Headquarters

Quarry Bay, HK

PRE Financials

Key Financial Metrics (TTM)

Gross Margin

58.32%

Operating Margin

-33.69%

Net Income Margin

-62.45%

Return on Equity

-46.74%

Return on Capital

-21.57%

Return on Assets

-40.52%

Earnings Yield

-25.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$319.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

17.14M

Volume

42.54K

Avg. Volume

237.55K

Financials (TTM)

Gross Profit

$66.34M

Operating Income

-$38.33M

EBITDA

-$51.68M

Operating Cash Flow

-$33.94M

Capital Expenditure

-$208.00K

Free Cash Flow

-$34.14M

Cash & ST Invst.

$106.04M

Total Debt

$457.00K

Prenetics Global Performance Analysis

Prenetics Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 13,163,841-95.2%
20232023-12-31USD 21,742,67565.2%
20242024-12-31USD 15,936,000-26.7%
20252025-12-31USD 92,390,000479.8%
Prenetics Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-302.1%
Q32025-09-3033.2%
Q42025-12-3155.2%
Q12026-03-31-1.7%
Prenetics Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -37.57154.4%
20232023-12-31USD -5.58-85.2%
20242024-12-31USD -3.71-33.6%
20252025-12-31USD -2.68-27.6%
Prenetics Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-17.5%
Q32025-09-3043.6%
Q42025-12-31-230.2%
Q12026-03-3122.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$35.95M

+107.7%

Gross Profit

$23.28M

+217.1%

Gross Margin

64.76%

N/A

Market Cap

$319.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.26M

N/A

Employees

98

N/A

Net Income

-$23.10M

-122.4%

EBITDA

-$9.52M

+13.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$106.04M

+81.2%

Total Debt

$457.00K

-91.1%

Accounts Receivable

$11.88M

+4.2%

Inventory

$14.20M

+114.8%

Long Term Debt

$50.00K

-98.0%

Short Term Debt

$407.00K

-84.4%

Return on Assets

-40.52%

N/A

Return on Invested Capital

-25.61%

N/A

Free Cash Flow

-$12.12M

N/A

Operating Cash Flow

-$12.12M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OSUROraSure Technologies, Inc.
$4.05+2.02%
PROFProfound Medical Corp.
$7.38+1.79%
TLSITriSalus Life Sciences, Inc.
$4.54-0.44%
IMDXInsight Molecular Diagnostics Inc.
$4.65+1.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About PRE

What is the current price of Prenetics Global?

Prenetics Global is trading at $18.64 per share.

What is the 52-week range for Prenetics Global?

Over the past 52 weeks, Prenetics Global has traded between $7.18 and $23.63.

How much debt does Prenetics Global have?

As of the most recent reporting period, Prenetics Global reported total debt of $457.00K.

How much cash does Prenetics Global have on hand?

Prenetics Global reported $56.02M in cash and cash equivalents in its most recent financial results.

What is Prenetics Global’s dividend yield?

Prenetics Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services